// App-Quantinova.ai

1430 : Switching from Synthetic to Biologic Dmards – Is There an Insufficient Use of Methotrexate?

Researchers

Presenter

  • Lisa Baganz

Principal Investigators

  • Adrian Richter

  • Yvette Meiner

  • Matthias Schneider

  • Anke Liebhaber

  • Ilka Schwarze

  • Anja Strangfeld

  • Angela Zink

Medical Centers

  • German Rheumatism Research Centre, Berlin, Germany

  • Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz institute, Berlin, Germany

  • Department of Rheumatology, Univ. Duesseldorf, Dusseldorf, Germany

  • Rheumatologist, Halle, Germany, Halle, Germany

  • Rheumatologist, Leipzig, Germany, Leipzig, Germany

  • Epidemiology unit, German Rheumatism Research Center, Berlin, Germany

  • Epidemiology Unit, German Rheumatism Research Centre and Charite University Medicine, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved